Short answer
CYTOKINETICS INC (CYTK) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 8.01 (Other Events). $800.0 million gross equity offering at $71.00 per share, including fully exercised 1,478,873-share option.
CYTOKINETICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $800.0 million gross equity offering at $71.00 per share, including fully exercised 1,478,873-share option
- Approximately $760.2 million net proceeds, materially strengthening Cytokinetics’ funding capacity
- 11,338,028 total shares issued, creating dilution for existing shareholders
- Proceeds support corporate purposes, but filing does not specify allocation across programs or operations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CYTOKINETICS INC 8-K filings
Get the next CYTK 8-K as it lands
Follow CYTK for push alerts, or ask the research agent what this filing means.